Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27529881 | 0.87 | CYP1A2 (0.36) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL1582418 | 0.83 | CYP1A2 (0.37) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL27859031 | 0.83 | MAPT (0.36) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL3246345 | 0.81 | CYP1A2 (0.36) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL15016045 | 0.81 | CYP1A2 (0.48) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL10855865 | 0.80 | OPRM1 (0.36) | — | |
| SCHEMBL2962933 | 0.76 | CYP1A2 (0.41) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL13759584 | 0.75 | CYP1A2 (0.43) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL11501675 | 0.75 | — | — | |
| SCHEMBL15015968 | 0.75 | CYP1A2 (0.43) | CYP1A2MAPK1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1647555-B1 | THE C-GLYCOSYLISOFLAVONES HAVING ALKYLAMINOALKOXYL SUBSTITUENT, THE PREPARATION AND THE USE OF THE SAME | INST RADIATION MED AMMS PLA (CN) | 2011-04-20 | — | — | EP | claimed |
| US-20100296994-A1 | CATALYST AND METHOD FOR DISMUTATION OF HALOSILANES CONTAINING HYDROGEN | EVONIK DEGUSSA GMBH (DE) | 2010-11-25 | — | — | US | claimed |
| US-7727965-B2 | C-glycosylisoflavones having alkylaminoalkoxyl substituent, preparation and use of the same | HAINAN YANGPU NEW & SPECIAL MEDICINE CO., LTD. (CN) | 2010-06-01 | — | — | US | claimed |
| US-20080293642-A1 | C-Glycosylisoflavones Having Alkylaminoalkoxyl Substituent, Preparation and Use of the Same | INSTITUTE OF RADIATION MEDICINE, ACADEMY OF MILITARY MEDICAL SCIENCES, PLA (CN) | 2008-11-27 | — | — | US | claimed |
| EP-1647555-A1 | THE C-GLYCOSYLISOFLAVONES HAVING ALKYLAMINOALKOXYL SUBSTITUENT, THE PREPARATION AND THE USE OF THE SAME | Institute of Radiation Medicine Academy of Military Medical Sciences of the Pla (CN) | 2006-04-19 | — | — | EP | claimed |
| US-20230029231-A1 | AQUEOUS INKJET PRINTING INK COMPOSITION | SAKATA INX CORPORATION (JP) | 2023-01-26 | — | — | US | disclosed |
| CN-114270572-A | Binder for electricity storage device | 富士胶片株式会社 | 2022-04-01 | — | — | CN | disclosed |
| US-11224844-B2 | Porous membrane for water treatment use | KANEKA CORPORATION (JP) | 2022-01-18 | — | — | US | disclosed |
| CN-113711393-A | Binder for electricity storage device for improving dispersibility of conductive auxiliary agent | 富士胶片和光纯药株式会社 | 2021-11-26 | — | — | CN | disclosed |
| WO-2021132179-A1 | AQUEOUS INKJET PRINTING INK COMPOSITION | サカタインクス株式会社 | 2021-07-01 | — | — | WO | disclosed |
| EP-3805862-A1 | LIQUID DEVELOPER | Kao Corporation (JP) | 2021-04-14 | — | — | EP | disclosed |
| WO-2021039960-A1 | BINDER FOR ELECTRICITY STORAGE DEVICES | 富士フイルム株式会社 | 2021-03-04 | — | — | WO | disclosed |
| US-20100069237-A1 | MESOPOROUS SILICA PARTICLES | KAO CORPORATION (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20100035791-A1 | TREATMENT COMPOSITION FOR TEXTILE PRODUCTS | KAO CORPORATION (JP) | 2010-02-11 | — | — | US | disclosed |
| EP-2078696-A1 | MESOPOROUS SILICA PARTICLES | Kao Corporation (JP) | 2009-07-15 | — | — | EP | disclosed |
| EP-2071072-A1 | TREATMENT COMPOSITION FOR TEXTILE PRODUCTS | Kao Corporation (JP) | 2009-06-17 | — | — | EP | disclosed |
| US-20080293642-A1 | C-Glycosylisoflavones Having Alkylaminoalkoxyl Substituent, Preparation and Use of the Same | INSTITUTE OF RADIATION MEDICINE, ACADEMY OF MILITARY MEDICAL SCIENCES, PLA (CN) | 2008-11-27 | — | — | US | disclosed |
| EP-1984484-A2 | SOIL RELEASING AGENT FOR FIBER | Kao Corporation (JP) | 2008-10-29 | — | — | EP | disclosed |
| EP-1972326-A1 | SKIN OR HAIR WASHING COMPOSITION | Kao Corporation (JP) | 2008-09-24 | — | — | EP | disclosed |
| WO-2007094505-A2 | SOIL RELEASING AGENT FOR FIBER | KAO CORPORATION (JP) | 2007-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293642-A1 | C-Glycosylisoflavones Having Alkylaminoalkoxyl Substituent, Preparation and Use of the Same | UGCG, PIGO, GPI | CYP1A2 259/4885MAPK1 2535/4885CA12 492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.